- United States
- /
- Pharma
- /
- NasdaqCM:RDHL
Three Undiscovered Gems in the United States Market
Reviewed by Simply Wall St
The market is up 3.1% over the last week, with the Information Technology sector up 4.6%. Over the past 12 months, the market is up 25%, and earnings are forecast to grow by 15% annually. In this thriving environment, identifying stocks with strong fundamentals and growth potential can lead to significant opportunities for investors.
Top 10 Undiscovered Gems With Strong Fundamentals In The United States
Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
---|---|---|---|---|
Morris State Bancshares | 10.20% | -0.32% | 6.73% | ★★★★★★ |
River Financial | 122.41% | 16.43% | 18.50% | ★★★★★★ |
Mission Bancorp | 25.37% | 16.23% | 20.16% | ★★★★★★ |
Teekay | NA | -6.48% | 55.79% | ★★★★★★ |
First Northern Community Bancorp | NA | 7.12% | 10.04% | ★★★★★★ |
Omega Flex | NA | 1.31% | 3.88% | ★★★★★★ |
Valhi | 38.71% | 2.57% | -19.76% | ★★★★★☆ |
Tiptree | 68.59% | 20.55% | 20.06% | ★★★★★☆ |
Village Super Market | 17.52% | 6.27% | 19.60% | ★★★★☆☆ |
FRMO | 0.17% | 12.99% | 23.62% | ★★★★☆☆ |
Let's uncover some gems from our specialized screener.
Helport AI (NasdaqCM:HPAI)
Simply Wall St Value Rating: ★★★★★☆
Overview: Helport AI Limited is an AI technology company that offers intelligent products, solutions, and a digital platform to enhance business-to-customer communication and sales performance, with a market cap of $317.57 million.
Operations: Helport AI generates revenue primarily from its Software & Programming segment, totaling $21.31 million. The company has a market cap of $317.57 million.
Helport AI, a small cap stock, has shown impressive growth with earnings increasing by 208% over the past year, outpacing the Software industry’s 23%. Its net debt to equity ratio stands at a satisfactory 4.5%, and interest payments are well covered by EBIT at 403.5x coverage. Recently added to the NASDAQ Composite Index on August 6, Helport AI trades at a significant discount of 88% below its estimated fair value despite high volatility in share price over the last three months.
- Click here and access our complete health analysis report to understand the dynamics of Helport AI.
Evaluate Helport AI's historical performance by accessing our past performance report.
RedHill Biopharma (NasdaqCM:RDHL)
Simply Wall St Value Rating: ★★★★★☆
Overview: RedHill Biopharma Ltd. is a specialty biopharmaceutical company that primarily focuses on gastrointestinal and infectious diseases, with a market cap of $256.99 million.
Operations: RedHill Biopharma Ltd. derives its revenue from the sale of specialty biopharmaceutical products targeting gastrointestinal and infectious diseases. The company has a market cap of $256.99 million.
RedHill Biopharma, a small cap stock, recently reported a significant one-off gain of US$54.6M for the year ending December 31, 2023. The company is debt-free and has maintained this status for over five years. Despite becoming profitable last year, its share price has been highly volatile over the past three months. Recent developments include the launch of Talicia in the UAE and positive results from studies on opaganib for Type 2 diabetes treatment.
- Delve into the full analysis health report here for a deeper understanding of RedHill Biopharma.
Assess RedHill Biopharma's past performance with our detailed historical performance reports.
Hovnanian Enterprises (NYSE:HOV)
Simply Wall St Value Rating: ★★★★★☆
Overview: Hovnanian Enterprises, Inc., through its subsidiaries, designs, constructs, markets, and sells residential homes in the United States with a market cap of $1.18 billion.
Operations: Hovnanian Enterprises generates revenue primarily from its homebuilding operations in the West ($1.35 billion), Northeast ($935.87 million), and Southeast ($480.25 million) regions, along with financial services contributing $66.16 million.
Hovnanian Enterprises has shown promising performance, with earnings growing by 20.3% over the past year, surpassing the Consumer Durables industry growth of 0.5%. The company’s interest payments are well covered by EBIT at 6.5 times coverage, indicating strong financial health despite a high net debt to equity ratio of 141.9%. Recently added to multiple Russell indices and completing a significant share buyback program (10.52% for US$36.82 million), Hovnanian's outlook appears robust amidst its high-quality earnings and strategic repurchases.
- Navigate through the intricacies of Hovnanian Enterprises with our comprehensive health report here.
Make It Happen
- Click through to start exploring the rest of the 219 US Undiscovered Gems With Strong Fundamentals now.
- Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
- Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.
Contemplating Other Strategies?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqCM:RDHL
RedHill Biopharma
A specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases.
Excellent balance sheet with acceptable track record.